Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06070233 · ClinicalTrials.gov registry record · NA
Radiosurgery Treatment for Spasticity Associated With Stroke, SCI & Cerebral Palsy
A NA study of Spasticity, Muscle and Spasticity as Sequela of Stroke, sponsored by Ohio State University.
- Recruiting
- Registry status
- NA
- Development phase
- 22
- Enrollment target
- 2
- Study locations
NCT06070233: Recruiting NA study of Spasticity, Muscle and Spasticity as Sequela of Stroke, sponsored by Ohio State University.
NCT06070233 is a NA study of Spasticity, Muscle and Spasticity as Sequela of Stroke that is actively recruiting participants, run by Ohio State University. The registered enrollment target is 22 participants, below the 78-participant average among 11 other Spasticity, Muscle trials with a reported enrollment target (72% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06070233, a NA study of Spasticity, Muscle and Spasticity as Sequela of Stroke, is actively recruiting participants, sponsored by Ohio State University.
- RECRUITING
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
- 2
- Study locations
Study Summary
A scientific study is being done to test a special treatment for people who have spasticity or tight muscles. This treatment is called "stereotactic radiosurgery dorsal rhizotomy." It uses very accurate beams of radiation to target certain nerves in the back to help loosen up the muscles. In this study, people are put into two groups by chance: one group gets the real treatment, and the other group gets a "fake" treatment that doesn't do anything. This fake treatment is called a "sham." Doing this helps make sure the study is fair and the results are true. After the people in the study get their treatment, the researchers will watch and see how they do. They will check if their muscles are less stiff and if they have any side effects. By looking at the results from both groups, the researchers can find out if the special treatment really helps people with spasticity. Patients who got the "fake" treatment will be eligible to receive the "real" treatment after 6 months.
Primary Outcome
Change in the 6-month post-treatment Modified Ashworth Scale (MAS) measure of spasticity, which ranges from 0 (no symptoms) to 4 (worst symptoms)
Conditions Studied
Interventions
- OTHER Sham
- RADIATION stereotactic radiosurgery (SRS) dorsal root rhizotomy radiomodulation
Study Locations (2)
Florida
- Renaissance Institute of Precision Oncology & Radiosurgery - Winter Park
Ohio
- Ohio State University Wexner Medical Center - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2023-10-12 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
What NCT06070233 shows while recruiting
NCT06070233 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 22 participants, a relatively small participant target, below the 78-participant average among 11 other Spasticity, Muscle trials with a reported enrollment target (72% lower).
The record links to 3 conditions, with Spasticity, Muscle appearing as the primary indexed condition, and to 2 interventions - of which Sham is the first listed.
NCT06070233 reports a single indexed study location in Florida, Ohio.
Frequently Asked Questions
What is clinical trial NCT06070233 about?
NCT06070233 is a clinical study titled "Radiosurgery Treatment for Spasticity Associated With Stroke, SCI & Cerebral Palsy". A scientific study is being done to test a special treatment for people who have spasticity or tight muscles. This treatment is called "stereotactic radiosurgery dorsal rhizotomy." It uses very accurate beams of radiation to target certain nerves in the back to help loosen up the muscles. In this st...
What is the current status of trial NCT06070233?
This trial is currently recruiting. It is a NA study. The enrollment target is 22 participants. The study started on 2023-10-12. Estimated completion is 2026-12-31.
What conditions does trial NCT06070233 study?
This clinical trial studies the following conditions: Spasticity, Muscle, Spasticity as Sequela of Stroke, Spastic Cerebral Palsy.
What interventions are being tested in trial NCT06070233?
The interventions under investigation include: Sham (OTHER), stereotactic radiosurgery (SRS) dorsal root rhizotomy radiomodulation (RADIATION).
Who is sponsoring clinical trial NCT06070233?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06070233 being conducted?
This trial has 2 study locations across Florida, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spasticity, Muscle
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06070233's enrollment target sits among peer trials
22 9th of 11 higher than 3 of 11 other Spasticity, Muscle trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Spasticity, Muscle trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Operant Conditioning of Spinal Reflexes Training System--Reflex Operant Down Conditioning
RECRUITING · NA
-
Transcutaneous Spinal Stimulation for Lower Limb Spasticity in Spinal Cord Injury
RECRUITING · NA
-
Activating Spinal Circuits to Improve Walking, Balance, Strength, and Reduce Spasticity
RECRUITING · NA
-
Extracorporeal Shockwave Therapy for Spasticity in People With Spinal Cord Injury
RECRUITING · NA
-
DDN in Stroke--COBRE
COMPLETED · NA
-
Melpida: Recombinant Adeno-associated Virus (serotype 9) Encoding a Codon Optimized Human AP4M1 Transgene (hAP4M1opt)
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02508038 · 22 participants · Phase 1
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- NCT03099356 · 22 participants · Phase 2
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
- NCT03676647 · 22 participants
Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
- NCT04569591 · 22 participants · NA
DDAVP for Pituitary Adenoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI